| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.7 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.7 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.7 |